Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 16, 2017- Late-breaking oral abstract presented at the World Congress of Gastroenterology -
-
Oct 11, 2017- Understand AD: A Day in the Life, Raises Awareness of Atopic Dermatitis by Sharing Real Stories from the AD Community, Driving Empathy and Understanding of this Unrelenting, Chronic Disease -
-
Oct 5, 2017- Praluent continues to be available to patients in the U.S. -
-
Sep 28, 2017- First targeted biologic in the European Union to receive marketing authorization for use in atopic dermatitis -
-
Sep 20, 2017- In preclinical studies, trispecific antibodies show exceptional potency against diverse HIV viruses -
-
Sep 20, 2017- Investigational RNAi Therapeutic Patisiran Meets Primary and All Secondary Endpoints, with Highly Significant Reduction In Neuropathy Progression and Improvement in Quality of Life at 18 Months Relative to Placebo -
-
Sep 16, 2017- Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress -
-
Sep 12, 2017-- More adults reached HbA(1c) target at 8 and 12 weeks versus those receiving insulin glargine 100 Units/mL --